Scheduling delegate's final decisions: June 2011

Scheduling medicines & poisons

1 June 2011

Delegate only and final decisions on matters initially referred to ACCS#1, ACMS#2 and ACCS-ACMS#2 (February 2011)

How to access a pdf or Word document

*Large file warning: Attempting to open large pdf files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Contents

  • Glossary
  • Part A - Final decisions on proposals referred to an advisory committee
    • 1. Matters initially referred to ACCS#1 - February 2011
      • 1.1 Cefquinome
      • 1.2 Derquantel
      • 1.3 Diethylhexyl phthalate
      • 1.4 Emodepside
      • 1.5 Flumioxazin
      • 1.6 MavacoxibEmodepside
      • 1.7 Metofluthrin
      • 1.8 Proquinazid
    • 2. Matters initially referred to ACMS#2 - February 2011
      • 2.1 Proposed changes to Part 4 of the SUSMP (The Schedules)
        • 2.1.1 Chloramphenicol
        • 2.1.2 Fexofenadine
        • 2.1.3 Ibuprofen
        • 2.1.4 Ibuprofen combined with Paracetamol
      • 2.2 Proposed changes to Part 5 of the SUSMP (The Appendices)
        • 2.2.1 Asenapine
        • 2.2.2 Pantoprazole
        • 2.2.3 Rupatadine
        • 2.2.4 Tafluprost
        • 2.2.5 Tapentadol
        • 2.2.6 Tolvaptan
    • 3. Matters initially referred to ACCS-ACMS#2 – February 2011
      • 3.1 Methylsulfonylmethane / Dimethyl sufone
  • Part B - Final decisions on matters not referred to an advisory committee
    • 4. Chemicals
      • 4.1 Bispyribac
      • 4.2 Toceranib
    • 5. Medicines
      • 5.1 Apixaban
      • 5.2 Canakinumab
      • 5.3 Eculizumab
      • 5.4 Fingolimod
      • 5.5 Ticagrelor
      • 5.6 Vernakalant
    • 6. Editorials and errata

Top of page